ShoenfeldY, TalA, BerlinerS, PinkhasJ. Leukocytosis in non-hematological malignancies: a possible tumor-associated marker. J Cancer Res Clin Oncol, 1986; 111(1):54–58.
2.
FerrignoD, BuccheriG. Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patients. Monaldi Arch Chest Dis, 2003; 59(3):193–198.
3.
GrangerJM, KontoyiannisDP. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer, 2009; 115(17):3919–3923.
4.
QureshiKM, RamanAK, TanD, FakihMG. Leukemoid reaction in pancreatic cancer: a case report and review of the literature. JOP, 2006; 7(6):631–634.
5.
KasugaI, MakinoS, KiyokawaH, KatohH, EbiharaY, OhyashikiK. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer, 2001; 92(9):2399–2405.
6.
LissoniP, FumagalliL, BrivioF, RovelliF, MessinaG, Di FedeG, et al. Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology. J Biol Regul Homeost Agents, 2006; 20(1–2):29–35.
7.
LangerCJ, ChoyH, GlaspyJA, ColowickA. Standards of care for anemia management in oncology: focus on lung carcinoma. Cancer, 2002; 95(3):613–623.
8.
CellaD. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol, 1998; 25(3 Suppl 7):43–46.
9.
VogelzangNJ, BreitbartW, CellaD. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol, 1997; 34(3 Suppl 2):4–12.
10.
BrizelDM, DodgeRK, CloughRW, DewhirstMW. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol, 1999; 53(2):113–117.
11.
EnganT, HannisdalE. Blood analyses as prognostic factors in primary lung cancer. Acta Oncol, 1990; 29(2):151–154.
12.
GislasonT, NouE. Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study. Eur J Respir Dis, 1985; 66(2):141–146.
13.
AlexandrakisMG, PassamFH, PerisinakisK, GanotakisE, MargantinisG, KyriakouDS, BourosD. Serum pro-inflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. Respir Med, 2002; 96(8):553–558.
14.
AoeK, HirakiA, UeokaH, KiuraK, TabataM, TanakaM, TanimotoM. Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration, 2004; 71(2):170–173.
15.
PanditR, ScholnikA, WulfekuhlerL, DimitrovN. Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome. Am J Hematol, 2007; 82(3):234–237.
